Sphingosine-1-phosphate: An emerging therapeutic target

Expert Opinion on Therapeutic Targets

Volumn 5, Issue 1, 2001, Pages 109-123

  Toman, Rachelle E ^a   Milstien, Sheldon ^b   Spiegel, Sarah ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

allergic response; angiogenesis; apoptosis; cancer; cell migration; ceramide; EDG receptor; neurodegenerative disorders; sphingosine kinase; sphingosine 1 phosphate

Indexed keywords

EID: 33746820446     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.5.1.109     Document Type: Review

References (104)

1. KOLESNICK R, HANNUN YA: Ceramide and apoptosis. Trends Biochem. Sci. (1999) 24:224-225.
2. HANNUN YA, LUBERTO C: Ceramide in the eukaryotic stress response. Trends Cell Biol. (2000) 10:73-80.
3. SPIEGEL S, MERRILL AH, JR.: Sphingolipid metabolism and cell growth regulation. FASEB J. (1996) 10:1388-1397.
4. KOLESNICK RN, KRONKE M: Regulation of ceramide production and apoptosis. Ann. Rev. Physiol. (1998) 60:643-665.
5. OLIVERA A, SPIEGEL S: Sphingosine-1-phosphate as a second messenger in cell proliferation induced by PDGFand FCS mitogens. Nature (1993) 365:557-560.
6. CUVILLIER O, PIRIANOV G, KLEUSER B et al: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature (1996) 381:800-803.
7. EDSALL LC, PIRIANOV GG, SPIEGEL S: Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. J. Neurosci. (1997) 17:6952-6960.
8. CUVILLIER O, ROSENTHAL DS, SMULSON ME, SPIEGEL S: Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas-and ceramide-mediated apoptosis in Jurkat T lymphocytes. J. Biol. Chem. (1998) 273:2910-2916.
9. KLEUSER B, CUVILLIER O, SPIEGEL S: 1Alpha,25-dihydroxyvitamin D3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase. Cancer Res. (1998) 58:1817-1824.
10. AN S, ZHENG Y, BLEU T: Sphingosine 1-phosphate-induced cell proliferation, survival and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5. J. Biol. Chem. (2000) 275:288-296.
11. PEREZ GI, KNUDSON CM, LEYKIN L, KORSMEYER SJ, TILLY JL: Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nature Med. (1997) 3:1228-1232.
12. MORITA Y, PEREZ GI, PARIS F et al.: Oocyte apoptosis is suppressed by disruption of the acid sphingomyeli nase gene or by sphingosine-1-phosphate therapy. Nature Med. (2000) 6:1109-1114.
13. OLIVERA A, KOHAMA T, TU Z, MILSTIEN S, SPIEGEL S: Purification and characterization of rat kidney sphingosine kinase. J. Biol Chem. (1998) 273:12576-12583.
14. KOHAMA T, OLIVERA A, EDSALL L et al: Molecular cloning and functional characterization of murine sphingosine kinase. J. Biol Chem. (1998) 273:23722-23728.
15. NAVA VE, LACANA E, POULTON S et al: Functional characterization of human sphingosine kinase-1. FEBS Lett. (2000) 473:81-84.
16. OLIVERA A, KOHAMA T, EDSALL LC et al: Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival.J. Cell Biol (1999) 147:545-558.
17. LIU H, SUGIURA M, NAVA VE et al: Molecular cloning and functional characterization of a novel mammalian sphingosine kinase Type2 isoform. J. Biol Chem. (2000) 275:19513-19520.
18. BORNFELDT KE, GRAVES LM, RAINES EW et al: Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction.J. Cell Biol (1995) 130:193-206.
19. PYNE S, CHAPMAN J, STEELE L, PYNE NJ: Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle cells. Eur. J. Biochem. (1996) 237:819-826.
20. CORONEOS E, MARTINEZ M, MCKENNA S, KESTER M: Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. J.Biol. Chem. (1995) 270:23305-23309.
21. RIUS RA, EDSALL LC, SPIEGEL S: Activation of sphingosine kinase in pheochromocytoma PC12 neuronal cells in response to trophic factors. FEBSLett. (1997) 417:173-176.
22. MEYER ZU HERINGDORF D, LASS H, ALEMANY R et al: Sphingosine kinase-mediated Ca2+ signalling by G-protein-coupled receptors. EMBO J. (1998) 17:2830-2837.
23. XIA P, GAMBLE JR, RYE KA et al: Tumor necrosis factor-a induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl. Acad. Sci. USA (1998) 95:14196-14201.
24. NIKOLOVA-KARAKASHIAN M, MORGAN ET, ALEXANDER C, LIOTTA DC, MERRILL AH, JR.: Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11. J. Biol Chem. (1997) 272:18718-18724.
25. CHOI OH, KIM J-H, KINETJ-P: Calcium mobilization via sphingosine kinase in signalling by the FcERI antigen receptor. Nature (1996) 380:634-636.
26. MELENDEZ A, FLOTO RA, GILLOOLY DJ, HARNETT MM, ALLEN JM: Fc-RI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. J. Biol Chem. (1998) 273:9393-9402.
27. MATTIE M, BROOKER G, SPIEGEL S: Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. J. Biol Chem. (1994) 269:3181-3188.
28. RANI CS, BERGER A, WU J et al: Divergence in signal transduction pathways of PDGF and EGF receptors: involvement of sphingosine-1-phosphate in PDGFbut not EGF signaling. J. Biol Chem. (1997) 272:10777-10783.
29. VAN BROCKLYN JR, LEE MJ, MENZELEEV R et al: Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled orphan receptor edg-1 and intracellular to regulate proliferation and survival. J. Cell Biol (1998) 142:229-240.
30. EDSALL LC, CUVILLIER O, TWITTY S, SPIEGEL S, MILSTIEN S: Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. J. Neurochem. (2000).
31. BRINDLEY DN, WAGGONER DW: Mammalian lipid phosphate phosphohydrolases. J. Biol Chem. (1998) 273:24281-24284.
32. MANDALA SM, THORNTON R, TU Z et al: Sphingoid base 1-phosphate phosphatase: a key regulator of sphingolipid metabolism and stress response. Proc. Natl. Acad. Sci. USA (1998) 95:150-155.
33. MAO C, WADLEIGH M, JENKINS GM, HANNUN YA, OBEID LM: Identification and characterization of Saccharo-myces cerevisiae dihydrosphingosine-1-phosphate phosphatase. J. Biol. Chem. (1997) 272:28690-28694.
34. QIE L, NAGIEC MM, BALTISBERGER JA, LESTER RL, DICKSON RC: Identification of a Saccharomyces gene, LCB3, necessary for incorporation of exogenous long chain bases into sphingolipids. J. Biol. Chem. (1997) 272:16110-16117.
35. MANDALA SM, THORNTON R, GALVE-ROPERH I et al.: Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1- phosphate and induces cell death. Proc. Natl. Acad. Sci. USA (2000) 97:7859-7864.
36. SABA JD, NARA F, BIELAWSKA A, GARRETT S, HANUN YA: The BST1 gene of Saccharomyces cerevisiae is the sphingosine-1-phosphate lyase. J. Biol. Chem. (1997) 272:26087-26090.
37. GOTTLIEB D, HEIDEMAN W, SABA JD: The DPL1 gene is involved in mediating the response to nutrient deprivation in Saccharomyces cerevisiae. Mol. Cell Biol. Res. Commun. (1999) 1:66-71.
38. ZHOU J, SABAJD: Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast. Biochem. Biophys. Res. Commun. (1998) 242:502-507.
39. VAN VELDHOVEN PP, GIJSBERS S, MANNAERTS GP, VERMEESCH JR, BRYS V: Human sphingosine-1-phosphate lyase: cDNAcloning,functional expression studies and mapping to chromosome 10q22(1). Biochim. Biophys. Acta (2000) 1487:128-134.
40. YATOMI Y, OHMORI T, RILE G et al.: Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood (2000) 96:3431-3438.
41. LEE MJ, VAN BROCKLYN JR, THANGADA S et al.: Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science (1998) 279:1552-1555.
42. SPIEGEL S, MILSTIEN S: Functions of a new family of sphingosine-1- phosphate receptors. Biochim. Biophys. Acta (2000) 1484:107-116.
43. GOETZL EJ, AN S: Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEBJ. (1998) 12:1589-1598.
44. HLA T, LEE MJ, ANCELLIN N et al.: Sphingosine-1-phosphate: extracellular mediator or intracellular second messenger? Biochem. Pharmacol. (1999) 58:201-207.
45. VAN BROCKLYN JR, TU Z, EDSALL LC, SCHMIDT RR, SPIEGEL S: Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218. J. Biol. Chem. (1999) 274:4626-4632.
46. CHUN J, CONTOS JJ, MUNROE D: A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs) [In Process Citation]. Cell Biochem. Biophys. (1999) 30:213-242.
47. HLA T, MACIAG T: An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein coupled receptors. J. Biol. Chem. (1990) 265:9308-9313.
48. YATOMI Y, IGARASHI Y, YANG L et al.: Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. (1997) 121:969-973.
49. POSTMA FR, JALINK K, HENGEVELD T, MOOLENAAR WH: Sphingosine-1-phosphate rapidly induces rho-dependent neurite retraction: action through a specific cell surface receptor. EMBO J. (1996) 15:2388-2392.
50. MACLENNAN AJ, BROWE CS, GASKIN AA, LADO DC, SHAW G: Cloning and characterization of a putative G-protein coupled receptor potentially involved in development. Mol. Cell Neurosci. (1994) 5:201-209.
51. GLICKMAN M, MALEK RL, KWITEK-BLACK AE, JACOB HJ, LEE NH: Molecular cloning, tissue-specific expression and chromosomal localization of a novel nerve growth factor-regulated G-protein-coupled receptor, nrg-1. Mol. Cell. Neurosci. (1999) 14:141-152.
52. MACLENNAN AJ, MARKS L, GASKIN AA, LEE N: Embryonic expression pattern of H218, a G-protein coupled receptor homolog, suggests roles in early mammalian nervous system development. Neurosci-ence (1997) 79:217-224.
53. MACLENNAN AJ, DEVLIN BK, MARKS L et al.: Antisense studies in PC12 cells suggest a role for H218, a sphingosine 1-phosphate receptor, in growth-factor-induced cell-cell interaction and neurite outgrowth. Dev. Neurosci. (2000) 22:283-295.
54. EDSALL LC, VAN BROCKLYN JR, CUVILLIER O,KLEUSER B, SPIEGEL S: N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry (1998) 37:12892-12898.
55. TARNOWSKI A, BÄR T, SCHMIDT RR: Efficient synthesis of sphingosine-1-phosphonate and homo-sphingosine-1-phosphonate. Bioorg. Medicinal Chem. Lett. (1997) 7:573-576.
56. XIA P, WANG L, GAMBLE JR, VADAS MA: Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J. Biol. Chem. (1999) 274:34499-34505.
57. JENKINS GM, RICHARDSA, WAHL Tet al.: Involvement of yeast sphingolipids in the heat stress response of Saccharomyces cerevisiae. J. Biol. Chem. (1997) 272:32566-32572.
58. DICKSON RC, NAGIEC EE, SKRZYPEK M et al.: Sphingolipids are potential heat stress signals in Saccharomyces. J. Biol. Chem. (1997) 272:30196-30200.
59. HANNUN YA, OBEID LM: Mechanisms of ceramide-mediated apoptosis. Adv. Exp. Med. Biol. (1997) 407:145-149.
60. SPIEGEL S, MILSTIEN S: Sphingosine-1-phosphate: signaling inside and out. FEBS Lett. (2000) 476:55-67.
61. ALEMANY R, SICHELSCHMIDT B, ZU HERINGDORF DM et al.: Stimulation of sphingosine-1-phosphate formation by the P2Y(2) receptor in HL-60 cells: Ca(2+) requirement and implication in receptor-mediated Ca(2+) mobilization, but not MAP kinase activation. Mol. Pharmacol. (2000) 58:491-497.
62. ALEMANY R, MEYER ZU HERINGDORF D, VAN KOPPEN CJ, JAKOBS KH: Formyl peptide receptor signaling in HL-60 cells through sphingosine kinase. J. Biol. Chem. (1999) 274:3994-3999.
63. SU Y, ROSENTHAL D, SMULSON M, SPIEGEL S: Sphingosine 1-phosphate, a novel signaling molecule, stimulates DNA binding activity of AP-1 in quiescent Swiss 3T3 fibroblasts. J. Biol. Chem. (1994) 269:16512-16517.
64. SHATROV VA, LEHMANN V, CHOUAIB S: Sphingosine-1-phosphate mobilizes intracellular calcium and activates transcription factor NF-?B in U937 cells. Biochem. Biophys. Res. Commun. (1997) 234:121-124.
65. HANNUN YA, BELL RM: Functions of sphingolipid and sphingolipid breakdown products in cellular regula tion. Science (1989) 243:500-507.
66. KING CC, ZENKE FT, DAWSON PE et al.: Sphingosine is a novel activator of 3-phosphoinositide-dependent kinase 1. J. Biol. Chem. (2000) 275:18108-18113.
67. WANG F, VAN BROCKLYN JR, EDSALL L, NAVA VE, SPIEGEL S: Sphingosine-1-phosphate inhibits motility of human breast cancer cells independently of cell surface receptors. Cancer Res. (1999) 59:6185-6191.
68. PITSON SM, MORETTI PA, ZEBOL JR et al.: Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation: a dominant negative sphingosine kinase. J. Biol. Chem. (2000) : in press.
69. HANNUN Y: Functions of ceramide in coordinating cellular responses to stress. Science (1996) 274:1855-1859.
70. CAIZ, BETTAIEB A, MAHDANI NE et al: Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-alpha-mediated cytotoxicity. J. Biol. Chem. (1997) 272:6918-6926.
71. KIMURA K, BOWEN C, SPIEGEL S, GELMANN EP: Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis. Cancer Res. (1999) 7:1606-1614.
72. NAVA VE, CUVILLIER O, EDSALL LC et al.: Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res. (2000) 60:4468-4474.
73. ENDO K, IGARASHIY, NISAR M, ZHOU QH, HAKOMORIS: Cell membrane signaling as target in cancer therapy: inhibitory effect of N,N-dimethyl and N,N,N-trimethyl sphingosine derivatives on in vitro and in vivo growth of human tumor cells in nude mice. Cancer Res. (1991) 51:1613-1618.
74. PING SE, BARRETT GL: Ceramide can induce cell death in sensory neurons, whereas ceramide analogues and sphingosine promote survival. J. Neurosci. Res. (1998) 54:206-213.
75. LEIST M, NICOTERA P: Apoptosis, excitotoxicity and neuropathology. Exp. Cell Res. (1998) 239:183-201.
76. SHINPO K, KIKUCHI S, MORIWAKA F, TASHIRO K: Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons. Brain Res. (1999) 819:170-173.
77. HARTFIELD PJ, MAYNE GC, MURRAY AW: Ceramide induces apoptosis in PC12 cells. FEBS Lett. (1997) 401: 148-152.
78. BRUGG B, MICHEL PP, AGID Y, RUBERG M: Ceramide induces apoptosis in cultured mesencephalic neurons. J. Neurochem. (1996) 66:733-739.
79. MITOMA J, ITO M, FURUYA S, HIRABAYASHI Y: Bipoten-tial roles of ceramide in the growth of hippocampal neurons: promotion of cell survival and dendritic outgrowth in dose-and developmental stage-dependent manners.J.Neurosci. Res. (1998) 51:712-722.
80. TANIWAKIT, YAMADA T, ASAHARA H, OHYAGIY, KIRA J: Ceramide induces apoptosis to immature cerebellar granule cells in culture. Neurochem. Res. (1999) 24:685-690.
81. KUBOTA M, NARITA K, NAKAGOMI T et al: Sphingomyelin changes in rat cerebral cortex during focal ischemia. Neurol. Res. (1996) 18:337-341.
82. KUBOTA M, KITAHARA S, SHIMASAKI H, UETA N: Accumulation of ceramide in ischemic human brain of an acute case of cerebral occlusion. Jpn. J. Exp. Med. (1989) 59:59-64.
83. XIA P, VADAS MA, RYE KA, BARTER PJ, GAMBLE JR: High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL. J. Biol Chem. (1999) 274:33143-33147.
84. SACHINIDIS A, KETTENHOFEN R, SEEWALD S et al: Evidence that lipoproteins are carriers of bioactive factors. Arterioscler. Thromb. Vasc. Biol. (1999) 19:2412-2421.
85. MURATA N, SATO K, KON J et al: Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. (2000) 352:809-815.
86. IGARASHI J, MICHEL T: Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS. Activationby sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J. Biol. Chem. (2000) 275:32363-32370.
87. JOHNS DG, CHARPIE JR, WEBB RC: Isceramide signaling a target for vascular therapeutic intervention? Curr. Pharm. Des. (1998) 4:481-488.
88. CHARLES R, SANDIRASEGARANE L, YUN J et al.: Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries. Circ. Res. (2000) 87:282-288.
89. KUPPERMAN E, AN S, OSBORNE N, WALDRON S, STAINIER DY: A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development. Nature (2000) 406:192-195.
90. HOLT PG, MACAUBAS C, STUMBLES PA, SLY PD: The role of allergy in the development of asthma. Nature (1999) 402:B12-B17.
91. PRIESCHL EE, CSONGA R, NOVOTNY V, KIKUCHI GE, BAUMRUKER T: The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering. J. Exp. Med. (1999) 190:1-8.
92. BAUMRUKER T, PRIESCHL EE: The role of sphingosine kinase in the signaling initiated at the high-affinity receptor for IgE (FcepsilonRI) in mast cells. Int. Arch. Allergy Immunol. (2000) 122:85-90.
93. MATHES C, FLEIG A, PENNER R: Calcium release-activated calcium current (ICRAC) is a direct target for sphingosine. J. Biol. Chem. (1998) 273:25020-25030.
94. FOLKMAN J: Angiogenesisin cancer, vascular, rheumatoid and other disease. Nature Med. (1995) 1:27-31.
95. FOLKMAN J, D'AMORE PA: Blood vesselformation: what is its molecular basis? Cell (1996) 87:1153-1155.
96. LEE OH, KIM YM, LEE YM et al.: Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. (1999) 264:743-750.
97. WANG F, VAN BROCKLYN JR, HOBSON JP et al.: Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J. Biol. Chem. (1999) 274:35343-35350.
98. LEE MJ, THANGADA S, CLAFFEY KP et al.: Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell (1999) 99:301-312.
99. ENGLISH D, KOVALA AT, WELCH Z et al.: Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis. J. Hematother. Stem Cell Res. (1999) 8:627-634.
100. HISANO N, YATOMI Y, SATOH K et al: Induction and suppression of endothelial cell apoptosis by sphingolipids: a possible in vitro model for cell-cell interactions between platelets and endothelial cells. Blood (1999) 93:4293-4299.
101. ENGLISH D, WELCH Z, KOVALA AT et al: Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEBJ. (2000) 14:2255-2265.
102. TAKADA Y, KATO C, KONDO S, KORENAGA R, ANDO J: Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem. Biophys. Res. Commun. (1997) 240:737-741.
103. LIU Y, WADA R, YAMASHITAT et al: Edg-1,the G-protein coupled receptor for sphingosine-1-phosphae, is essential for vascular maturation. J. Clin. Invest. (2000) 106:951-961.
104. SCHWARTZ GK, WARD D, SALTZ L et al.: A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin. Clin. Cancer Res. (1997) 3:537-543.